Detalles de la búsqueda
1.
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma.
Blood
; 137(1): 49-60, 2021 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32693406
2.
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies.
Clin Chem Lab Med
; 61(12): 2115-2130, 2023 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37477188
3.
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Br J Haematol
; 197(1): 76-81, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881427
4.
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study.
Mod Pathol
; 34(1): 59-69, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32999413
5.
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Blood
; 127(25): 3165-74, 2016 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118453
6.
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy.
Blood
; 134(24): 2218-2222, 2019 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31697808
7.
Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance rounds.
Cytometry A
; 87(2): 145-56, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345353
8.
Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil.
Cancers (Basel)
; 15(5)2023 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900396
9.
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study.
Blood Cancer J
; 13(1): 182, 2023 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072838
10.
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index.
Blood Cancer J
; 13(1): 177, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040702
11.
Altered innate immune profile in blood of systemic mastocytosis patients.
Clin Transl Allergy
; 12(6): e12167, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734269
12.
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels.
Cancers (Basel)
; 14(3)2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158741
13.
Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma.
Arch Pathol Lab Med
; 146(7): 862-871, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619755
14.
Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study.
Blood Adv
; 6(3): 976-992, 2022 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814179
15.
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.
J Clin Oncol
; 40(27): 3151-3161, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666958
16.
CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.
Haematologica
; 96(2): 328-32, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20971816
17.
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.
Haematologica
; 96(5): 687-95, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21330323
18.
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638406
19.
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
Cancers (Basel)
; 13(6)2021 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810169
20.
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.
Cancers (Basel)
; 13(7)2021 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33916787